Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹327 Cr
Revenue (TTM)
₹556 Cr
Net Profit (TTM)
₹21 Cr
ROE
9.4 %
ROCE
14.9 %
P/E Ratio
15.5
P/B Ratio
1.4
Industry P/E
45.36
EV/EBITDA
6.1
Div. Yield
0 %
Debt to Equity
0.5
Book Value
₹--
EPS
₹3.2
Face value
2
Shares outstanding
66,188,500
CFO
₹164.15 Cr
EBITDA
₹173.66 Cr
Net Profit
₹73.80 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Artemis Global
| -22.9 | -6.4 | -1.6 | -32.5 | -- | -- | -- |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
BSE Healthcare#
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2018
|
|---|---|
|
Artemis Global
| -44.9 |
|
BSE Sensex
| 5.9 |
|
BSE Healthcare
| -5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Artemis Global
|
49.5 | 327.3 | 555.8 | 21.0 | 8.3 | 7.3 | 15.5 | 1.4 |
| 2,110.2 | 17,282.6 | 1,215.1 | 284.8 | 28.7 | 21.1 | 60.2 | 11.4 | |
| 656.2 | 12,893.6 | 7,266.8 | 627.5 | 11.9 | 12.6 | 20.5 | 2.4 | |
| 613.6 | 15,214.7 | 5,092.5 | 545.5 | 15.9 | 14.1 | 27.9 | 3.7 | |
| 839.3 | 13,375.6 | 7,918.4 | 429.9 | 10.7 | 7.2 | 30.9 | 2.0 | |
| 1,027.6 | 18,409.8 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 11.8 | 2.1 | |
| 1,404.5 | 16,092.2 | 1,419.3 | 20.1 | 8.4 | 0.5 | 800.5 | 2.8 | |
| 142.2 | 18,882.0 | 8,871.4 | -223.5 | 1.9 | -1.6 | -- | 2.4 | |
| 391.1 | 15,752.9 | 3,720.2 | 352.1 | 13.7 | 8.2 | 44.7 | 3.3 | |
| 1,271.5 | 20,670.6 | 3,151.0 | -10.0 | 8.4 | 2.5 | 939.6 | 4.5 |
No Review & Analysis are available.
Manufacture of basic iron and steel
Incorporated
2011
Chairman
Onkar S Kanwar
Managing Director
Devlina Chakravarty
Group
Raunaq Singh
Headquarters
New Delhi, Delhi
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Artemis Global Life Sciences Ltd is ₹49.45 (NSE) and ₹51.00 (BSE) as of 23-Oct-2019 IST. Artemis Global Life Sciences Ltd has given a return of -32.54% in the last 1 years.
The P/E ratio of Artemis Global Life Sciences Ltd is 15.51 times as on 23-Oct-2019, a 66 discount to its peers’ median range of 45.36 times.
The P/B ratio of Artemis Global Life Sciences Ltd is 1.41 times as on 23-Oct-2019, a 55 discount to its peers’ median range of 3.12 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2019
|
19.64
|
1.77
|
|
2018
|
24.69
|
3.12
|
|
2017
|
0.00
|
0.00
|
|
2016
|
0.00
|
0.00
|
|
2015
|
0.00
|
0.00
|
The 52-week high and low of Artemis Global Life Sciences Ltd are Rs -- and Rs -- as of 02-Apr-2026.
Artemis Global Life Sciences Ltd has a market capitalisation of ₹ 327 Cr as on 23-Oct-2019. As per SEBI classification, it is a company.
Before investing in Artemis Global Life Sciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-1.65
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.